Current Status and Prospect of Interventional Congenital Heart Disease

Slides:



Advertisements
Similar presentations
CONGENITAL HEART DISEASE.
Advertisements

Pulmonary Atresia and Intact Ventricular Septum
Cyanotic Congenital Heart Disease
Congenital Heart Disease Cheston M. Berlin, Jr., M.D. Department of Pediatrics.
Congenital Heart Defects Fred Hill, MA, RRT. Categories of Heart Defects Left-to-right shunt Cyanotic heart defects Obstructive heart defects.
Update of Transcatheter Closure of Ventricular Septal Defect in China Yong-wen Qin Department of Cardiology, Changhai Hospital, Second Military Medical.
Acyanotic Congenital Heart Disease
Double Outlet Right Ventricle
Congenital Heart Disease: Outcome in Patients with Single Ventricle
Pulmonary Atresia and Intact Ventricular Septum
Ebstein’s Malformation
HOW TO DEAL WITH A NEWBORN BABY WITH CONGENITAL HEART DISEASE ?
Congenital Heart Defects
Atrial and Ventricular Hypertrophy. ECG Features and Common Causes.
Valvular Heart Disease. Normal heart valves function to maintain the direction of blood flow through the atria and ventricles to the rest of the body.
HOW I DO IT ? MODIFIED NORWOOD’S OPERATION
Aetiology * MVP { Myxomatous mv },commonest in developed world *Damage to the cusps : _RVD _ IE _ Congenital Cleft MV *Damage to chordae : _RVD.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
Principal Groups of CHD
Islamic University of Gaza Faculty of Nursing Pediatric Nursing
CONGENITAL DISEASES Dr. Meg-angela Christi Amores.
Congenital Heart Disease Emad Al Khatib, RN,MSN,CNS.
INTRODUCTION A 35 year old woman with transposition of the great arteries repaired with a Mustard procedure attends your clinic for annual follow-up. Her.
Pulmonary Atresia with Intact Ventricular Septum
Prepared by Dr Nahed El- nagger Assistant professor of Nursing
Congenital Mitral Valve Disease
Tetralogy of Fallot, Pulmonary Atresia, with MAPCAs Technique for Early Complete Repair Frank Hanley.
Ebstein’s anomaly Polina Petrovic July Definition Congenital cardiac malformation characterized by apical displacement of septal and posterior tricuspid.
Palliative Operation Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Causes of valve disease Valve regurgitation * Congenital *Acute rheumatic carditis *Chronic rhe. Carditis * I E *Syphlitic aortitis *Dilated Valve.
One & A Half Ventricle Repair
Management of Adult Congenital Heart Disease Alpay Çeliker MD. Hacettepe University Department of Pediatric Cardiology.
Pulmonary Atresia with Intact Ventricular Septum Ali Sepahdari, MD University of Illinois at Chicago.
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
Department of Cardiolog Shenyang Northern Hospital
Congenital Heart Disease Most occur during weeks 3 to 8 Incidence 6 to 8 per 1,000 live born births Some genetic – Trisomies 13, 15, 18, & 21 and Turner.
Author: Denisa Pop 1 Second Authors: Dominic Pascal Keller 1 Roxana Costache 1 Tamas Szabo 1 Coordinators: Medical Doctor Valentin Stroe 2 Professor Horatiu.
Cardiovascular surgery, Congenital heart disease Dr. Robin Man Karmacharya, Lecturer, Department of Surgery, Dhulikhel Hospital.
Cardiothoracic Surgery. Topics Valvotomy and valve replacement Open heart surgery and cardiac bypass surgery Correction of congenital heart diseases Heart.
NURSING CARE OF THE CHILD WITH A CARDIOVASCULAR DISEASE Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture 9.
AORTIC-LEFT VENTRICULAR TUNNEL. BASICS –CONNECTION BETWEEN AORTA AND LV, NOT INVOLVING THE AORTIC VALVE –USUALLY ARISE FROM R CORONARY SINUS, MOST COMMONLY.
Truncus Arteriosus Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Percutaneous Establishment of Tricuspid Regurgitation: An Experimental Model for Transcatheter Tricuspid Valve Replacement Yuan Bai, Gang-jun Zong, Yong-wen.
Intervention of Aortic Coarctation: from Angioplasty to Stent
Adult with operated congenital heart disease: what should we check for? January 15 th, h-17h30.
CONGENITAL HEART DISEASES
Cardiopulmonary Disorders. Common Cardiac Disorders Coronary Artery Disease Myocardial Infarction (MI) Heart Murmurs/Valvular Heart Disease Congestive.
Physiology Congenital Heart Disease Bill Cayley MD MDiv University of Wisconsin.
Congenital Heart Disease. Aetiology and incidence The incidence 0.8% of live births. Maternal infection or exposure to drugs or toxins may cause congenital.
H. Amoozgar, MD Professor of pediatric cardiology Shiraz University of Medical Sciences, Shiraz, Iran TRANSCATHETER CLOSURE OF LARGE CORONARY-CAMERAL FISTULAE.
Congenital Heart Disease
POSTER 1 7:10 – 7:17 Initial Clinical Experience with the GORE® CARDIOFORM ASD Occluder for Transcatheter Atrial Septal Defect Closure Presenter: Quentin.
VSD post TAVR: Mechanisms, Presentation and Management
Cardiovascular system
Congenital Heart Disease
Cyanotic congenital heart diseases Krzysztof Narebski Torun
Special Hospital for surgical diseases “Filip Vtori”, Skopje
Pediatric cardiac catheterization Part 1 - balloon procedures David Shim, MD The Heart Center Children’s Hospital Medical Center Cincinnati, Ohio.
Objectives 1-To discuss V.S.D.
Mohamed Eid Fawzy, FRCP, FACC, FESC October 6 University Cairo, EGYPT
One-stop Hybrid Cardiac Surgery
THE “UNDER-LINING” CAUSE OF RIGHT HEART FAILURE AFTER CARDIAC SURGERY
S.G. Worthley, MB, BS, PhD., S. Redwood, MD, PhD.,
Congenital Diseases Dr. Gerrard Uy.
Adult Congenital Heart Disease Overview of the Population at Risk
Balu Vaidyanathan, Sumantha Sekhar Padhi, Ananthen KS, BRJ Kannan,
B. Zane Atkins, MD, Zubair A. Hashmi, MD, Asvin M. Ganapathi, MD, J
Bidirectional Glenn shunt in association with congenital heart repairs: the 112 ventricular repair  Constantine Mavroudis, MD, Carl L Backer, MD, Lisa.
UK paediatric cardiac surgery 30-day mortality rates for individual specific procedures by era (2000–2004 compared with 2005–2010). UK paediatric cardiac.
Prevalence of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) according to defect. Prevalence of pulmonary arterial.
Presentation transcript:

Current Status and Prospect of Interventional Congenital Heart Disease 先天性心脏病介入治疗现状及展望 Fu Wai Hospital Cardiovascular Institute Chinese Academy of Medical Sciences Dai Ru Ping 戴汝平 2009.11.13

Current Situation on CHD Intervention (2009) In China, 0.15 million newborn have CHD per year. 0.1millin patients need treat by surgery. Up to the present, total 2.5 million patients who have various CHD in China. 50 thousand were treated by surgery per year. 30 thousand were treated by Intervention in 2009 (estimated). Homemade devices were used in 3/4--4/5 ps.

Current Status of CHD Interventions CHD ASD PDA VSD PS Others Total Case 12000 8000 7000 3000 --- 30000

Current Status of CHD Interventions Homemade Devices were used in 3/4--4/5 ps. Hybrid procedure were performed Good results with low complications

Homemade Devices Biocompatibility study of Domestic Devices VSD ASD PDA Biocompatibility study of Domestic Devices

Homemade Devices PDA,ASD,VSD, Occluders Quality Price

Hybrid Procedure More than 20 hospitals performed Hybrid procedure Balloon atrial septostomy Embolization to occlude aortopulmonary collateral vessels and shunts Balloon angioplasty ,Stenting for branch pulmonary artery stenoses Stent implantation of the arterial duct in newborns with duct- dependent circulation Transcatheter occlusion of residual interatrial communications after Fontan Procedure. Laser valvotomy with balloon valvoplasty for pulmonary atresia with intact ventricular septum

Hybrid Procedure for alternative treating complex CHD with cyanosis Balloon atrial septostomy for alternative treating complex CHD with cyanosis

Hybrid Procedure Embolization to occlude aortopulmonary collateral vessels and shunts for treating PA+VSD

Hybrid Procedure Stenting for treating branch pulmonary artery stenoses

Hybrid Procedure for treating pulmonary atresia Laser valvotomy with balloon valvoplasty for treating pulmonary atresia

Complications of VSD intervention ( No 9311) Complication Number % III°AVB 63(8) 0.72% TI 60 0.60% Residual shunt (6 month) 36(8980) 0.40% Hemolysis 25 0.27% Device migration 16 0.17% Outlet stenosis of RV 14 0.15% AI 9 0.10% Cardiomegaly 6 0.07% Tamponade 5 0.05% Stroke 2 0.02% MI 1 0.01% Death 5 0.05% Total 242 2.60% Successful rate:96.40% Mortality:0.05% (Data from 2007 CHD Salon)

Later Complications ( 6m-2y after ) 1, PH with right cardiac failure. 2, Arrhythmia (LBBB, II-III°AV-B; Pacemaker-6m) 3, Cardiomegaly with heart failure. 4, Device migration . 5, Tamponade ( Occluder Erosion ). 6, Stenosis of RV Outlet. 7, Valvular damage (AI ,TI, MI )

Later Complications Pulmonary hypertension with right heart failure RV LV LV F 12y,ECG:RVH,TTE:ASD : 11mm, Treated by Interventional technique with Amplazer occluder of 18mm。 After 2 years, die from right heart failure , Pulmonary systolic pressure:153mmHg (by Echo) Plex & arteritis

Later Complications Cardiomegaly with left heart failure. pre Immediately Post 1 year M 3y,ECG:Normal,TTE:VSD : 4mm, Treated by Interventional technique with Amplazer occluder of 6mm. ECG : CLBBB ( QRS : 152mS), immediately after intervention. After 1 years, Cardiomegaly with heart failure occurred.

Later Complications Tamponade ( occluder erosion of left atrial wall) Occlusion of ASD with Amplatzer device half year later, Tamponade occurred , due to occluder erosion of left atrial wall .

Later Complications Tricuspid damage (VSD) Tricuspid Insufficiency : Leaflet perforation due to procedure Chord rupture due to procedure Chord or / and leaflets were pressed by occluder TV&M-Aneurysm VSD & Chord Chord rupture + TI

Prospect of Interventional CHD Develop New Technique and Device National Support for Scientific Research Natural Scientific Found “863“ Scientific Found “11-5” National Support Plan Found Design New Occluder Transcatheter valve replacement Aortic Valve Pulmonary Valve

Prospect of Interventional CHD Transcatheter valve replacement

Prospect of Structural Heart Disease 1, Modify Guideline of Interventional SHD 2, National Permit: Interventional Technique 3, National Training Center. 4, “11-5” National Support Plan, Long-term results and long-term follow-up National registration of interventional cases 5, Develop new Technique

Thanks 谢谢